Related Experiment Video
Updated: Oct 7, 2026

The Visual Colorimetric Detection of Multi-nucleotide Polymorphisms on a Pneumatic Droplet Manipulation Platform
Published on: September 27, 2016
Nanopore sensing with machine learning-assisted analysis for real-time single-molecule detection of MDM2-p53TAD
Jinhyung Kim1, Taeyoung Ha2, Soyoung Park3
1Critical Diseases Diagnostics Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea; Department of Proteome Structural Biology, KRIBB School of Bioscience, University of Science and Technology, Daejeon, 34113, Republic of Korea.
Abstract:
Protein-protein interactions (PPIs) play pivotal roles in physiological processes but remain challenging drug targets. Conventional PPI detection methods often suffer from limited sensitivity and require time- and labor-intensive procedures, such as fluorophore labeling, restricting their utility in drug discovery. Here, we present a YaxAB nanopore sensing platform coupled with machine learning-assisted signal analysis for label-free, real-time, single-molecule detection of PPIs between the oncogenic murine double minute 2 (MDM2) protein and p53TAD1. Proteins were efficiently captured into the YaxAB nanopore, and free MDM2 generated ionic current signatures readily distinguishable from those of the MDM2-p53TAD1 complex. To enable rapid and quantitative event analysis, we developed a machine learning-based classification framework that accurately distinguished free MDM2, MDM2-p53TAD1 complexes, and MDM2-drug complexes directly from nanopore current traces. This integrated platform enabled automated interpretation of single-molecule events, real-time monitoring of PPI inhibition by small-molecule MDM2 antagonists, and estimation of drug binding affinity without labeling or ensemble averaging. Taken together, the YaxAB nanopore sensing and machine learning analysis platform provides a versatile approach for single-molecule interaction analysis, with potential applications in drug discovery, diagnostics, including protein probe-biomarker interaction assays.
